Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z)

Hirokazu Murakami; Tetsuhiro Kasamatsu; Jun Murakami; Toru Kiguchi; Takeshi Kanematsu; Daisuke Ogawa; Hiroyuki Takamatsu; Hiroshi Handa; Shuji Ozaki; Hirokazu Miki; Takeshi Takahashi; Takaaki Takeo; Tatsuya Yamauchi; Takanobu Morishita; Hiroshi Kosugi; Kazuyuki Shimizu

doi:10.1007/s12185-019-02663-5

Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z)

Hirokazu Murakami, Tetsuhiro Kasamatsu, Jun Murakami, Toru Kiguchi, Takeshi Kanematsu, Daisuke Ogawa, Hiroyuki Takamatsu, Hiroshi Handa, Shuji Ozaki, Hirokazu Miki, Takeshi Takahashi, Takaaki Takeo, Tatsuya Yamauchi, Takanobu Morishita, Hiroshi Kosugi, Kazuyuki Shimizu

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors would like to correct the errors in the publication of the original article. The correction details are given below.

Original language	English
Pages (from-to)	125-126
Number of pages	2
Journal	International Journal of Hematology
Volume	110
Issue number	1
DOIs	https://doi.org/10.1007/s12185-019-02663-5
Publication status	Published - 01-07-2019
Externally published	Yes

All Science Journal Classification (ASJC) codes

Hematology

Access to Document

10.1007/s12185-019-02663-5

Fingerprint

Dive into the research topics of 'Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z)'. Together they form a unique fingerprint.

Cite this

Murakami, H., Kasamatsu, T., Murakami, J., Kiguchi, T., Kanematsu, T., Ogawa, D., Takamatsu, H., Handa, H., Ozaki, S., Miki, H., Takahashi, T., Takeo, T., Yamauchi, T., Morishita, T., Kosugi, H., & Shimizu, K. (2019). Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z). International Journal of Hematology, 110(1), 125-126. https://doi.org/10.1007/s12185-019-02663-5

@article{292f107a9ec24c86a29045b9ef5f48c1,

title = "Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z)",

abstract = "The authors would like to correct the errors in the publication of the original article. The correction details are given below.",

author = "Hirokazu Murakami and Tetsuhiro Kasamatsu and Jun Murakami and Toru Kiguchi and Takeshi Kanematsu and Daisuke Ogawa and Hiroyuki Takamatsu and Hiroshi Handa and Shuji Ozaki and Hirokazu Miki and Takeshi Takahashi and Takaaki Takeo and Tatsuya Yamauchi and Takanobu Morishita and Hiroshi Kosugi and Kazuyuki Shimizu",

note = "Publisher Copyright: {\textcopyright} 2019, Japanese Society of Hematology.",

year = "2019",

month = jul,

day = "1",

doi = "10.1007/s12185-019-02663-5",

language = "English",

volume = "110",

pages = "125--126",

journal = "International Journal of Hematology",

issn = "0925-5710",

publisher = "Springer",

number = "1",

}

Murakami, H, Kasamatsu, T, Murakami, J, Kiguchi, T, Kanematsu, T, Ogawa, D, Takamatsu, H, Handa, H, Ozaki, S, Miki, H, Takahashi, T, Takeo, T, Yamauchi, T, Morishita, T, Kosugi, H & Shimizu, K 2019, 'Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z)', International Journal of Hematology, vol. 110, no. 1, pp. 125-126. https://doi.org/10.1007/s12185-019-02663-5

Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z). / Murakami, Hirokazu; Kasamatsu, Tetsuhiro; Murakami, Jun et al.
In: International Journal of Hematology, Vol. 110, No. 1, 01.07.2019, p. 125-126.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Correction to

T2 - Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z)

AU - Murakami, Hirokazu

AU - Kasamatsu, Tetsuhiro

AU - Murakami, Jun

AU - Kiguchi, Toru

AU - Kanematsu, Takeshi

AU - Ogawa, Daisuke

AU - Takamatsu, Hiroyuki

AU - Handa, Hiroshi

AU - Ozaki, Shuji

AU - Miki, Hirokazu

AU - Takahashi, Takeshi

AU - Takeo, Takaaki

AU - Yamauchi, Tatsuya

AU - Morishita, Takanobu

AU - Kosugi, Hiroshi

AU - Shimizu, Kazuyuki

PY - 2019/7/1

Y1 - 2019/7/1

N2 - The authors would like to correct the errors in the publication of the original article. The correction details are given below.

AB - The authors would like to correct the errors in the publication of the original article. The correction details are given below.

UR - http://www.scopus.com/inward/record.url?scp=85066898762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066898762&partnerID=8YFLogxK

U2 - 10.1007/s12185-019-02663-5

DO - 10.1007/s12185-019-02663-5

M3 - Comment/debate

C2 - 31119612

AN - SCOPUS:85066898762

SN - 0925-5710

VL - 110

SP - 125

EP - 126

JO - International Journal of Hematology

JF - International Journal of Hematology

IS - 1

ER -

Murakami H, Kasamatsu T, Murakami J, Kiguchi T, Kanematsu T, Ogawa D et al. Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z). International Journal of Hematology. 2019 Jul 1;110(1):125-126. doi: 10.1007/s12185-019-02663-5

Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z)

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this